PCA3 score accuracy in diagnosing prostate cancer at repeat biopsy: Our experience in 177 patients

Archivio Italiano di Urologia e Andrologia

Volumn 84, Issue 4, 2012, Pages 227-229

  Barbera, Michele ^a   Pepe, Pietro ^b   Paola, Quintino ^a   Aragona, Francesco ^b  

^a Azienda Ospedaliera Ospedali Civili Riuniti di Sciacca   (Italy)

^b CANNIZZARO HOSPITAL   (Italy)

Author keywords

PCA3 score; Prostate cancer; Repeat biopsy; Saturation prostate biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL EVALUATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PCA3 SCORE; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REPEAT PROCEDURE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BIOPSY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84872799307     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Walz J, Graefen M, Chun FK, et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006; 50:498-505. (Pubitemid 44189057)
2. Pepe P, Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007; 70:1131-1135. (Pubitemid 350297372)
3. Kirby R, Fitzpatrick JM. Optimising repeat prostate biopsy decisions and procedures. BJU Int 2012; 109:1750-1754.
4. Marks LS, Fradet Y, Deras IL, et al. PCA3 molecular urinary assay for prostate cancer in men undergoing repeat biopsy. Urology 2007; 69:532-535. (Pubitemid 46428401)
5. Pepe P, Aragona F. PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsy. Anticancer Research 2011; 31:4445-4449.
6. Haese A, de la Taille A, van Poppel H, et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol 2008; 54:1081-1088.
7. Aubin SM, Reid J, Sarno MJ, et al. PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of dutasteride REDUCE trial. J Urol 2010; 184:1947-1952.
8. Perdonà S, Cavadas V, Di Lorenzo G, et al. Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to head comparison of the update PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3. Eur Urol 2011; 59:81-87.
9. Pepe P, Fraggetta F, Galia A, et al. PCA3 Score and Prostate Cancer Diagnosis at Repeat Saturation Biopsy. Which cut-off: 20 or 35? Int Braz J Urol 2012; 38:489-495.
10. Ploussard G, Durand X, Xylinas E, et al. Prostate cancer 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance. Eur Urol 2011; 59:422-429.
11. Pepe P, Fraggetta F, Galia A, Aragona F. Is PCA3 score useful in preoperative staging a single microfocus of prostate cancer diagnosed at saturation biopsy? Urol Int 2012; 89:143-147.
12. Pepe P, Aragona F. Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14453 patients. Prostate Cancer Prostatic Dis 2010; 13:316-319.
13. Groskopf J, Aubin SM, Deras IL, et al. APTIMA molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 2006; 52:1089-1095. (Pubitemid 43794421)
14. Bostwick DG, Grignon DJ, Hammond ME, et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124:995-1000. (Pubitemid 30602040)
15. Epstein J, Walsh P and Carmichael M. Pathological and clinical findings to predict tumor extent of non palpable (stage T1c) prostate cancer. JAMA 1994; 271:368-374. (Pubitemid 24037911)
16. Vlaeminck-Guillem V, Devonec M, Colombel M, et al. Urinary PCA3 score predicts prostate cancer multifocality. J Urol 2011; 185:1234-1239.
17. Fradet Y, Saad F, Aprikian A, et al. uPM3, a new molecular urine test for the detection of prostate cancer. Urology 2004; 64:311-315.
18. Remzi M, Haese A, Van Poppel H, et al. Follow-up of men with an elevated PCA3 score and negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer? BJU Int 2010; 106:1138-1142.
19. Roobol MJ, Schroder FH, van Leenders GL, et al. Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 score (> 100). Eur Urol 2010; 58:893-899.